No abstract available
MeSH terms
-
Cardiovascular Diseases / chemically induced*
-
Cardiovascular Diseases / mortality
-
Diabetes Mellitus, Type 2 / drug therapy*
-
Drug Approval
-
Europe
-
Humans
-
Hypoglycemic Agents / adverse effects*
-
Myocardial Infarction / chemically induced
-
Rosiglitazone
-
Safety-Based Drug Withdrawals
-
Thiazolidinediones / adverse effects*
-
United States
-
United States Food and Drug Administration
Substances
-
Hypoglycemic Agents
-
Thiazolidinediones
-
Rosiglitazone